Janusz M J, Little C B, King L E, Hookfin E B, Brown K K, Heitmeyer S A, Caterson B, Poole A R, Taiwo Y O
Procter & Gamble Pharmaceuticals, Inc., Mason, OH 45050-9462, USA.
Osteoarthritis Cartilage. 2004 Sep;12(9):720-8. doi: 10.1016/j.joca.2004.06.004.
To characterize the time course of aggrecan and type II collagen degradation in the rat iodoacetate model of cartilage degeneration in relationship to the temporal sequence that has been described in human osteoarthritis (OA).
Rats were injected intra-articularly in one knee joint with iodoacetate and damage to the tibial plateau was assessed from digitized images captured using an image analyzer. The articular cartilage from the tibial plateau was harvested, extracted and glycosaminoglycan (GAG) content was measured using the dimethylmethylene blue (DMMB) assay. Cartilage aggrecan neoepitopes were detected in cartilage extracts by Western blotting using antibodies recognizing the aggrecanase-generated C-terminal neoepitope NITEGE (BC-13) and the MMP-generated C-terminal neoepitope DIPEN (BC-4). A type II collagen collagenase-generated neoepitope was detected in cartilage extracts by ELISA using the Col2-3/4Cshort antibody; denatured collagen was detected using the Col2-3/4m antibody.
Degenerative joint changes and proteoglycan (GAG) loss progressed with time after iodoacetate injection. Western blotting of cartilage extracts of iodoacetate treated rats demonstrated an increase in both aggrecanase- and MMP-generated epitopes with the NITEGE aggrecanase neoepitope being significantly elevated on days 7, 14 and 21 while DIPEN the MMP neoepitope was significantly elevated on days 7 and 14. The type II collagen neoepitope recognized by Col2-3/4Cshort was significantly increased in cartilage extracts of rats at days 14 and 21 after iodoacetate injection.
The proteoglycan fragments extracted from the knee cartilage of rats after the intra-articular injection of iodoacetate appeared to result from cleavage at both aggrecanase and MMP sites. Cleavage of type II collagen by collagenase was also detected after iodoacetate injection and occurred subsequent to the initiation of aggrecan loss. These observations serve to demonstrate similarities in the mechanisms of cartilage degeneration induced by iodoacetate to those seen in articular cartilage in OA.
在大鼠碘乙酸盐诱导的软骨退变模型中,描述聚集蛋白聚糖和II型胶原降解的时间进程,并将其与人类骨关节炎(OA)中所描述的时间顺序相关联。
给大鼠的一个膝关节进行关节腔内注射碘乙酸盐,使用图像分析仪从采集的数字化图像评估胫骨平台的损伤情况。采集胫骨平台的关节软骨,进行提取,并使用二甲基亚甲基蓝(DMMB)分析法测量糖胺聚糖(GAG)含量。通过蛋白质印迹法,使用识别聚集蛋白聚糖酶产生的C末端新表位NITEGE(BC - 13)和基质金属蛋白酶(MMP)产生的C末端新表位DIPEN(BC - 4)的抗体,检测软骨提取物中的软骨聚集蛋白聚糖新表位。通过酶联免疫吸附测定(ELISA),使用Col2 - 3/4Cshort抗体检测软骨提取物中II型胶原酶产生的新表位;使用Col2 - 3/4m抗体检测变性胶原。
注射碘乙酸盐后,随着时间推移,关节退变改变和蛋白聚糖(GAG)丢失不断进展。对碘乙酸盐处理大鼠的软骨提取物进行蛋白质印迹分析显示,聚集蛋白聚糖酶和MMP产生的表位均增加,其中聚集蛋白聚糖酶新表位NITEGE在第7、14和21天显著升高,而MMP新表位DIPEN在第7天和第14天显著升高。在注射碘乙酸盐后第14天和第21天,大鼠软骨提取物中Col2 - 3/4Cshort识别的II型胶原新表位显著增加。
关节腔内注射碘乙酸盐后,从大鼠膝关节软骨中提取的蛋白聚糖片段似乎是由聚集蛋白聚糖酶和MMP位点的切割产生的。注射碘乙酸盐后还检测到胶原酶对II型胶原的切割,且发生在聚集蛋白聚糖丢失开始之后。这些观察结果表明,碘乙酸盐诱导的软骨退变机制与OA关节软骨中的退变机制相似。